Celldex Therapeutics shares owned by Lindbrook Capital
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Lindbrook Capital
from 13F filings
Historical chart of Lindbrook Capital investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Lindbrook Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $6.5k | 155 | 41.97 |
| 2023-12-31 | $6.1k | 155 | 39.66 |
| 2023-09-30 | $0 | 0 | 0.00 |
| 2023-06-30 | $1.8k | 54 | 33.93 |
| 2023-03-31 | $1.5k | 43 | 35.98 |
| 2022-12-31 | $3.5k | 79 | 44.57 |
| 2022-09-30 | $0 | 3 | 0.00 |
| 2022-06-30 | $0 | 9 | 0.00 |
| 2022-03-31 | $2.0k | 52 | 38.46 |
| 2021-09-30 | $53k | 990 | 53.54 |
| 2021-03-31 | $21k | 1.0k | 21.00 |
| 2020-06-30 | $21k | 1.6k | 12.98 |